Pulmonary Arterial Hypertension Life Expectancy at Life

Pulmonary Arterial Hypertension Life Expectancy. There are, however, treatments that can improve the disease, including warfarin (coumadin), digoxin, and vasodilators, such as nifedipine, intravenous prostacyclin, or both. Idiopathic pulmonary arterial hypertension (formerly referred to as primary.

However, life expectancy has improved in recent years due to the availability of new diagnostic tests to detect the disease at an earlier stage as well as new treatments, such as targeted or advanced medications, to combat the condition. The survival rate of the patient with pulmonary hypertension depends on the etiology. Pulmonary hypertension is high blood pressure in the blood vessels that supply the lungs (pulmonary arteries).

Opsumit Relieves PAH, Halts Disease Associated Metabolic

The survival rate of the patient with pulmonary hypertension depends on the etiology. However, there was no significant difference for survival between the 2 groups (p =.1743). Some studies have shown that pulmonary hypertension life expectancy is as little as one year after diagnosis but can be five years or more. There is currently no cure for pulmonary hypertension, which compromises the growth, development and life expectancy of pediatric patients.